These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 16741971

  • 1. Antitumor efficacy of DNA vaccination to the epigenetically acting tumor promoting transcription factor BORIS and CD80 molecular adjuvant.
    Loukinov D, Ghochikyan A, Mkrtichyan M, Ichim TE, Lobanenkov VV, Cribbs DH, Agadjanyan MG.
    J Cell Biochem; 2006 Aug 01; 98(5):1037-43. PubMed ID: 16741971
    [Abstract] [Full Text] [Related]

  • 2. Reciprocal binding of CTCF and BORIS to the NY-ESO-1 promoter coincides with derepression of this cancer-testis gene in lung cancer cells.
    Hong JA, Kang Y, Abdullaev Z, Flanagan PT, Pack SD, Fischette MR, Adnani MT, Loukinov DI, Vatolin S, Risinger JI, Custer M, Chen GA, Zhao M, Nguyen DM, Barrett JC, Lobanenkov VV, Schrump DS.
    Cancer Res; 2005 Sep 01; 65(17):7763-74. PubMed ID: 16140944
    [Abstract] [Full Text] [Related]

  • 3. Conditional expression of the CTCF-paralogous transcriptional factor BORIS in normal cells results in demethylation and derepression of MAGE-A1 and reactivation of other cancer-testis genes.
    Vatolin S, Abdullaev Z, Pack SD, Flanagan PT, Custer M, Loukinov DI, Pugacheva E, Hong JA, Morse H, Schrump DS, Risinger JI, Barrett JC, Lobanenkov VV.
    Cancer Res; 2005 Sep 01; 65(17):7751-62. PubMed ID: 16140943
    [Abstract] [Full Text] [Related]

  • 4. Selective apoptosis of breast cancer cells by siRNA targeting of BORIS.
    Dougherty CJ, Ichim TE, Liu L, Reznik G, Min WP, Ghochikyan A, Agadjanyan MG, Reznik BN.
    Biochem Biophys Res Commun; 2008 May 23; 370(1):109-12. PubMed ID: 18355444
    [Abstract] [Full Text] [Related]

  • 5. DNA vaccines targeting tumor antigens to B7 molecules on antigen-presenting cells induce protective antitumor immunity and delay onset of HER-2/Neu-driven mammary carcinoma.
    Sloots A, Mastini C, Rohrbach F, Weth R, Curcio C, Burkhardt U, Jäger E, Forni G, Cavallo F, Wels WS.
    Clin Cancer Res; 2008 Nov 01; 14(21):6933-43. PubMed ID: 18980988
    [Abstract] [Full Text] [Related]

  • 6. Dynamic transcriptional regulatory complexes including BORIS, CTCF and Sp1 modulate NY-ESO-1 expression in lung cancer cells.
    Kang Y, Hong JA, Chen GA, Nguyen DM, Schrump DS.
    Oncogene; 2007 Jun 28; 26(30):4394-403. PubMed ID: 17260018
    [Abstract] [Full Text] [Related]

  • 7. Elicitation of T cell responses to histologically unrelated tumors by immunization with the novel cancer-testis antigen, brother of the regulator of imprinted sites.
    Ghochikyan A, Mkrtichyan M, Loukinov D, Mamikonyan G, Pack SD, Movsesyan N, Ichim TE, Cribbs DH, Lobanenkov VV, Agadjanyan MG.
    J Immunol; 2007 Jan 01; 178(1):566-73. PubMed ID: 17182597
    [Abstract] [Full Text] [Related]

  • 8. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.
    Sorensen MR, Holst PJ, Pircher H, Christensen JP, Thomsen AR.
    Eur J Immunol; 2009 Oct 01; 39(10):2725-36. PubMed ID: 19637230
    [Abstract] [Full Text] [Related]

  • 9. [Novel vaccines against M. tuberculosis].
    Okada M.
    Kekkaku; 2006 Dec 01; 81(12):745-51. PubMed ID: 17240920
    [Abstract] [Full Text] [Related]

  • 10. BORIS in human cancers -- a review.
    Martin-Kleiner I.
    Eur J Cancer; 2012 Apr 01; 48(6):929-35. PubMed ID: 22019212
    [Abstract] [Full Text] [Related]

  • 11. Improved efficacy of DNA vaccination against prostate carcinoma by boosting with recombinant protein vaccine and by introduction of a novel adjuvant epitope.
    Lu Y, Ouyang K, Fang J, Zhang H, Wu G, Ma Y, Zhang Y, Hu X, Jin L, Cao R, Fan H, Li T, Liu J.
    Vaccine; 2009 Aug 27; 27(39):5411-8. PubMed ID: 19616501
    [Abstract] [Full Text] [Related]

  • 12. Vaccination with a DNA vaccine based on human PSCA and HSP70 adjuvant enhances the antigen-specific CD8+ T-cell response and inhibits the PSCA+ tumors growth in mice.
    Zhang X, Yu C, Zhao J, Fu L, Yi S, Liu S, Yu T, Chen W.
    J Gene Med; 2007 Aug 27; 9(8):715-26. PubMed ID: 17595048
    [Abstract] [Full Text] [Related]

  • 13. Improved efficacy of DNA vaccination against breast cancer by boosting with the repeat beta-hCG C-terminal peptide carried by mycobacterial heat-shock protein HSP65.
    Yi H, Rong Y, Yankai Z, Wentao L, Hongxia Z, Jie W, Rongyue C, Taiming L, Jingjing L.
    Vaccine; 2006 Mar 24; 24(14):2575-84. PubMed ID: 16420967
    [Abstract] [Full Text] [Related]

  • 14. Epigenetic control of CTCFL/BORIS and OCT4 expression in urogenital malignancies.
    Hoffmann MJ, Müller M, Engers R, Schulz WA.
    Biochem Pharmacol; 2006 Nov 30; 72(11):1577-88. PubMed ID: 16854382
    [Abstract] [Full Text] [Related]

  • 15. Whole tumor cell vaccine with irradiated S180 cells as adjuvant.
    Li J, King AV, Stickel SL, Burgin KE, Zhang X, Wagner TE, Wei Y.
    Vaccine; 2009 Jan 22; 27(4):558-64. PubMed ID: 19027812
    [Abstract] [Full Text] [Related]

  • 16. MMP11: a novel target antigen for cancer immunotherapy.
    Peruzzi D, Mori F, Conforti A, Lazzaro D, De Rinaldis E, Ciliberto G, La Monica N, Aurisicchio L.
    Clin Cancer Res; 2009 Jun 15; 15(12):4104-13. PubMed ID: 19509157
    [Abstract] [Full Text] [Related]

  • 17. [Preparation of the monoclonal antibodies against human BORIS and the expression pattern of BORIS in normal and diseased human mammary tissues].
    Zhou XC, Song CJ, Wang X, Tian Y, Jin BQ.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Apr 15; 23(4):353-5. PubMed ID: 17428394
    [Abstract] [Full Text] [Related]

  • 18. Preventive vaccination with telomerase controls tumor growth in genetically engineered and carcinogen-induced mouse models of cancer.
    Mennuni C, Ugel S, Mori F, Cipriani B, Iezzi M, Pannellini T, Lazzaro D, Ciliberto G, La Monica N, Zanovello P, Bronte V, Scarselli E.
    Cancer Res; 2008 Dec 01; 68(23):9865-74. PubMed ID: 19047167
    [Abstract] [Full Text] [Related]

  • 19. Prophylactic anti-tumor effects in a B cell lymphoma model with DNA vaccines delivered on polyethylenimine (PEI) functionalized PLGA microparticles.
    Pai Kasturi S, Qin H, Thomson KS, El-Bereir S, Cha SC, Neelapu S, Kwak LW, Roy K.
    J Control Release; 2006 Jul 20; 113(3):261-70. PubMed ID: 16793161
    [Abstract] [Full Text] [Related]

  • 20. Surrogate tumor antigen vaccination induces tumor-specific immunity and the rejection of spontaneous metastases.
    Lewis JD, Shearer MH, Kennedy RC, Bright RK.
    Cancer Res; 2005 Apr 01; 65(7):2938-46. PubMed ID: 15805297
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.